| Literature DB >> 22087146 |
Emmanuel Andres1, Mustapha Mecili, Ecaterina Ciobanu.
Abstract
Entities:
Keywords: Cobalamin deficiency; Hepatitis B; Hepatitis C; Interferon-alpha; Pernicious anemia; Viral hepatitis
Year: 2011 PMID: 22087146 PMCID: PMC3206689
Source DB: PubMed Journal: Hepat Mon ISSN: 1735-143X Impact factor: 0.660
Characteristics of the patients
| Chronic active hepatitis B followed since at least 5 years of age with no treatment | Cobalamin deficiency: | Hashimoto’s thyroïd with anti-TPO antibodies | |
| • Loss of reflexes | |||
| • Megaloblastic anemia | |||
| • Serum vitamin B12 level <130 pg/mL | |||
| Pernicious anemia: | |||
| • Anti-intrinsic factor antibodies | |||
| • Autoimmune atrophic gastritis | |||
| Chronic active hepatitis C followed since 5 years of age and treated with interféron-α: 9 MU per week (subcutaneously) | Cobalamin deficiency: | - | |
| • Medullar combined sclerosis | |||
| • No hematological abnormality | |||
| • Serum vitamin B12 level <22 pg/mL | |||
| Pernicious anemia: | |||
| • Anti-intrinsic factor antibodies | |||
| • Malabsorption on the de Schilling’s test reversed with intrinsic factor | |||
| • Autoimmune atrophic gastritis | |||
| Chronic active hepatitis C treated since 7 months of age with interféron-α: 9 MU per week (subcutaneously) | Cobalamin deficiency: | Asymptomatic cryoglobulinemia | |
| • Loss of reflexes | |||
| • Megaloblastic anemia and thrombocytopenia | |||
| • Serum vitamin B12 level <150 pg/mL | |||
| Pernicious anemia: | |||
| • Anti-intrinsic factor antibodies | |||
| Mild chronic hepatitis C with no interferon-alpha treatment | Cobalamin deficiency: | Antinuclear antibodies | |
| • Sensitive peripheral neuropathy | |||
| • Megaloblastic anemia | |||
| • Serum vitamin B12 level <20 pg/mL | |||
| Pernicious anemia: | |||
| • Anti-intrinsic factor antibodies | |||
| • Autoimmune atrophic gastritis | |||
| Chronic hepatitis C with no interferon-alpha treatment | Cobalamin deficiency: | Celiac disease with malabsorption (iron, folate and calcium), duodal villous atrophy and antitransglutaminase antibodies | |
| • Sensitive peripheral neuropathy | |||
| • Macrocytosis (MCV = 105 fL) | |||
| • Serum vitamin B12 level <160 pg/mL | |||
| Pernicious anemia: | |||
| • Anti-intrinsic factor antibodies |
a Serum vitamin B12 levels were determined by radioimmunoassay (Bayer, New York, NY, USA).
b Schilling’s test was realized with a Dicopac test (Amersham Healthcare, Birmingham UK).